GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (HKSE:01177) » Definitions » Shiller PE Ratio

Sino Biopharmaceutical (HKSE:01177) Shiller PE Ratio : 12.56 (As of Dec. 12, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Sino Biopharmaceutical Shiller PE Ratio?

As of today (2024-12-12), Sino Biopharmaceutical's current share price is HK$3.39. Sino Biopharmaceutical's E10 for the fiscal year that ended in Dec23 was HK$0.27. Sino Biopharmaceutical's Shiller PE Ratio for today is 12.56.

The historical rank and industry rank for Sino Biopharmaceutical's Shiller PE Ratio or its related term are showing as below:

HKSE:01177' s Shiller PE Ratio Range Over the Past 10 Years
Min: 8.67   Med: 47.49   Max: 123.56
Current: 12.56

During the past 13 years, Sino Biopharmaceutical's highest Shiller PE Ratio was 123.56. The lowest was 8.67. And the median was 47.49.

HKSE:01177's Shiller PE Ratio is ranked better than
88.41% of 138 companies
in the Biotechnology industry
Industry Median: 38.49 vs HKSE:01177: 12.56

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sino Biopharmaceutical's adjusted earnings per share data of for the fiscal year that ended in Dec23 was HK$0.138. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is HK$0.27 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sino Biopharmaceutical Shiller PE Ratio Historical Data

The historical data trend for Sino Biopharmaceutical's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Shiller PE Ratio Chart

Sino Biopharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.25 48.29 22.16 17.71 12.83

Sino Biopharmaceutical Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 17.71 - 12.83 -

Competitive Comparison of Sino Biopharmaceutical's Shiller PE Ratio

For the Biotechnology subindustry, Sino Biopharmaceutical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sino Biopharmaceutical's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's Shiller PE Ratio falls into.



Sino Biopharmaceutical Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sino Biopharmaceutical's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=3.39/0.27
=12.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sino Biopharmaceutical's E10 for the fiscal year that ended in Dec23 is calculated as:

For example, Sino Biopharmaceutical's adjusted earnings per share data for the fiscal year that ended in Dec23 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec23 (Change)*Current CPI (Dec23)
=0.138/117.2957*117.2957
=0.138

Current CPI (Dec23) = 117.2957.

Sino Biopharmaceutical Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 0.091 99.707 0.107
201512 0.107 102.015 0.123
201612 0.110 103.225 0.125
201712 0.154 104.984 0.172
201812 0.554 107.622 0.604
201912 0.163 110.700 0.173
202012 0.175 109.711 0.187
202112 0.897 112.349 0.936
202212 0.136 114.548 0.139
202312 0.138 117.296 0.138

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sino Biopharmaceutical  (HKSE:01177) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Sino Biopharmaceutical Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sino Biopharmaceutical Business Description

Traded in Other Exchanges
Address
1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG
Listed on the Hong Kong Stock Exchange in 2000, Sino Biopharmaceutical is one of the largest Chinese drugmakers. It started with generic drug manufacturing. Since 2018, Sino Biopharm has been actively pivoting into an innovative drugmaker after the Chinese government launched its volume-based procurement policy for the healthcare industry. As of 2023, 37.8% of the firm's total revenue comes from five innovative drugs and five biosimilar drugs. Sino Biopharm's biggest revenue segment is oncology medicines, accounting for 33.6% of total revenue, followed by hepatitis, surgery/analgesia, respiratory, and cardio-cerebral vascular therapeutic areas.
Executives
Tse Eric S Y 2101 Beneficial owner
Tse Ping 2101 Beneficial owner
Cheng Cheung Ling 2101 Beneficial owner
True Merit Global Limited 2101 Beneficial owner
Tse Theresa Y Y 2101 Beneficial owner
Thousand Eagles Limited 2101 Beneficial owner
France Investment (china 1) Group Limited 2101 Beneficial owner
Remarkable Industries Limited 2101 Beneficial owner
Validated Profits Limited 2101 Beneficial owner

Sino Biopharmaceutical Headlines

No Headlines